查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1671185

抗凝固剂反转药的全球市场:市场规模·占有率·趋势，产业分析 (各产品·各流通管道·各地区)，未来预测 (2025年～2034年)

Anticoagulant Reversal Drugs Market Share, Size, Trends, Industry Analysis Report - By Product, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，抗凝血逆转药物市场规模预计到 2034 年将达到 4,486,470 亿美元。该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

心房颤动和心臟病等心血管疾病在世界各地变得越来越常见。患有这些疾病的患者需要服用抗凝血剂（血液稀释剂）来预防血栓。然而，抗凝血剂在某些情况下可能会增加过度出血的风险，因此需要抗凝血逆转剂来控制潜在的出血併发症。心血管疾病患者数量的不断增加促使对这些逆转药物的需求增加。因此，确保患者在治疗期间的安全是治疗过程的重要部分。心血管疾病盛行率的不断上升直接推动了抗凝血逆转药物市场的需求。

FDA 等监管机构对新型有效抗凝血逆转药物的批准正在推动抗凝血逆转药物市场的成长。 FDA 批准确保药物对公众使用是安全有效的，并在医疗保健提供者和患者之间建立信任。随着新型逆转药物的推出和批准，医生将拥有更多的治疗选择，并能够为每位患者选择最合适的药物。核准药物数量的增加将鼓励医疗保健系统采用这些新疗法，从而刺激市场。此类药物的持续批准有助于满足日益增长的医疗保健需求，并促进抗凝血逆转药物市场的发展。

抗凝血逆转药物市场报告重点

根据产品，idarucizumab 部门在 2024 年占据了抗凝血逆转药物市场占有率的主导地位，因为它在逆转常见血液稀释剂达比加群的作用方面具有很高的功效和特异性。

由于因出血性疾病住院的患者数量不断增加，医院药房市场占据最大的市场占有率。

由于直接报销政策的可用性和该地区先进的医疗保健行业等因素，预计北美将在 2024 年占据整个抗凝血逆转剂市场的收入占有率的主导地位。

由于医疗保健投资的增加和对血液稀释治疗的认识的提高，亚太地区的抗凝血逆转药物市场正在经历显着增长。

全球市场参与者包括 Alps Pharmaceutical Ind.Ltd.、AMAG Pharmaceuticals, Inc.、Bausch Health Companies Inc.、Boehringer Ingelheim、CSL Behring、Dr. Reddy's Laboratories、Fresenius Kabi AG、Octapharma AG、Pfizer, Inc.s 和 Pharmaceutical。以及久光製药株式会社

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球抗凝固剂反转药市场洞察

  • 市场概述
  • 抗凝固剂反转药的市场动态
    • 促进因素和机会
      • 扩大研究活动
      • 老年人口增加
    • 阻碍因素和课题
      • 监理障碍
  • 大环境分析
  • 抗凝固剂反转药市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球抗凝固剂反转药市场:各产品

  • 主要发现
  • 简介
  • 凝血酶原复合物浓缩物
  • 植物甲萘醌
  • Andexanet Alpha
  • 伊达赛珠单抗
  • 鱼精蛋白

第6章 全球抗凝固剂反转药市场:各流通管道

  • 主要的分析结果
  • 简介
  • 医院药局
  • 零售药局
  • 线上药局

第7章 全球抗凝固剂反转药市场:各地区

  • 主要的分析结果
  • 简介
    • 抗凝固剂反转药市场评估:各地区 (2020～2034年)
  • 北美
    • 北美:各产品 (2020～2034年)
    • 北美:各流通管道 (2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品 (2020～2034年)
    • 欧洲:各流通管道 (2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品 (2020～2034年)
    • 亚太地区:各流通管道 (2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品 (2020～2034年)
    • 中东·非洲:各流通管道 (2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各产品 (2020～2034年)
    • 南美:各流通管道 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第8章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第9章 企业简介

  • Alps Pharmaceutical Ind. Co., Ltd.
  • AMAG Pharmaceuticals, Inc.
  • Bausch Health Companies Inc.
  • Boehringer Ingelheim
  • CSL Behring
  • Dr. Reddy's Laboratories
  • Fresenius Kabi AG
  • Octapharma AG
  • Pfizer, Inc.
  • Portola Pharmaceuticals
  • Covis Pharma
  • Hisamitsu Pharmaceutical Co., Inc.
Product Code: PM1869

The anticoagulant reversal drugs market size is expected to reach USD 4,486.47 million by 2034, according to a new study by Polaris Market Research. The report "Anticoagulant Reversal Drugs Market Share, Size, Trends, Industry Analysis Report - By Product (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine, and Others), Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cardiovascular diseases, such as atrial fibrillation and heart attacks, are becoming common worldwide. Patients having these conditions require anticoagulants (blood thinners) to prevent blood clots. However, anticoagulants can increase the risk of excessive bleeding in some cases, creating a need for anticoagulant reversal drugs to manage potential bleeding complications. The growing number of individuals affected by cardiovascular conditions leads to an increased demand for these reversal drugs. This makes them an essential part of the treatment process, ensuring patient safety during therapy. The rise in the prevalence of cardiovascular diseases is directly driving the anticoagulant reversal drugs market demand.

The approval of new and effective anticoagulant reversal drugs by regulatory authorities such as the FDA is driving the anticoagulant reversal drug market growth. FDA approval ensures that a drug is safe and effective for public use, which builds trust among healthcare providers and patients. When new reversal drugs are introduced and approved, they provide more treatment options for doctors, allowing them to select the most appropriate medicine for each patient. This increased availability of approved drugs stimulates the market as healthcare systems adopt these newer treatments. The continuous approval of such drugs helps meet the growing healthcare demand, driving the anticoagulant reversal drugs market development.

Anticoagulant Reversal Drugs Market Report Highlights

By product, the idarucizumab segment dominated the anticoagulant reversal drugs market share in 2024 due to its high efficacy and specificity in reversing the effects of dabigatran, a common blood thinner.

The hospital pharmacy segment, based on distribution channel, accounts for the largest market share due to rising hospital admissions for distinct types of bleeding disorders.

In 2024, North America dominated the overall anticoagulant reversal drugs market revenue share due to factors such as the availability of direct refund policies and the region's advanced healthcare sector.

The Asia Pacific anticoagulant reversal drug market is experiencing significant growth due to increasing healthcare investments and rising awareness about blood thinning treatments.

A few global market players include Alps Pharmaceutical Ind. Co., Ltd.; AMAG Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Boehringer Ingelheim; CSL Behring; Dr. Reddy's Laboratories; Fresenius Kabi AG; Octapharma AG; Pfizer, Inc.; Portola Pharmaceuticals; Covis Pharma.; and Hisamitsu Pharmaceutical Co., Inc.

Polaris Market Research has segmented the anticoagulant reversal drugs market report on the basis of product, distribution channel, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

  • Prothrombin Complex Concentrates
  • Phytonadione
  • Andexanet Alfa
  • Idarucizumab
  • Protamine

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Anticoagulant Reversal Drugs Market Insights

  • 4.1. Anticoagulant Reversal Drugs Market - Market Snapshot
  • 4.2. Anticoagulant Reversal Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Research Activities
      • 4.2.1.2. Rise in Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Hurdle
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Anticoagulant Reversal Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Anticoagulant Reversal Drugs Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • 5.3. Prothrombin Complex Concentrates
    • 5.3.1. Global Anticoagulant Reversal Drugs Market, by Prothrombin Complex Concentrates, by Region, 2020-2034 (USD Million)
  • 5.4. Phytonadione
    • 5.4.1. Global Anticoagulant Reversal Drugs Market, by Phytonadione, by Region, 2020-2034 (USD Million)
  • 5.5. Andexanet Alfa
    • 5.5.1. Global Anticoagulant Reversal Drugs Market, by Andexanet Alfa, by Region, 2020-2034 (USD Million)
  • 5.6. Idarucizumab
    • 5.6.1. Global Anticoagulant Reversal Drugs Market, by Idarucizumab, by Region, 2020-2034 (USD Million)
  • 5.7. Protamine
    • 5.7.1. Global Anticoagulant Reversal Drugs Market, by Protamine, by Region, 2020-2034 (USD Million)

6. Global Anticoagulant Reversal Drugs Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Global Anticoagulant Reversal Drugs Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Million)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Anticoagulant Reversal Drugs Market, by Retail Pharmacy by Region, 2020-2034 (USD Million)
  • 6.5. Online Pharmacy
    • 6.5.1. Global Anticoagulant Reversal Drugs Market, by Online Pharmacy by Region, 2020-2034 (USD Million)

7. Global Anticoagulant Reversal Drugs Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Anticoagulant Reversal Drugs Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Anticoagulant Reversal Drugs Market - North America
    • 7.3.1. North America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.3.2. North America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.3.3. Anticoagulant Reversal Drugs Market - U.S.
      • 7.3.3.1. U.S.: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.3.3.2. U.S.: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.3.4. Anticoagulant Reversal Drugs Market - Canada
      • 7.3.4.1. Canada: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.4. Anticoagulant Reversal Drugs Market - Europe
    • 7.4.1. Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.4.2. Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.3. Anticoagulant Reversal Drugs Market - UK
      • 7.4.3.1. UK: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.4. Anticoagulant Reversal Drugs Market - France
      • 7.4.4.1. France: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.4.2. France: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.5. Anticoagulant Reversal Drugs Market - Germany
      • 7.4.5.1. Germany: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.6. Anticoagulant Reversal Drugs Market - Italy
      • 7.4.6.1. Italy: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.7. Anticoagulant Reversal Drugs Market - Spain
      • 7.4.7.1. Spain: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.8. Anticoagulant Reversal Drugs Market - Netherlands
      • 7.4.8.1. Netherlands: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.9. Anticoagulant Reversal Drugs Market - Russia
      • 7.4.9.1. Russia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.10. Anticoagulant Reversal Drugs Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.5. Anticoagulant Reversal Drugs Market - Asia Pacific
    • 7.5.1. Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.3. Anticoagulant Reversal Drugs Market - China
      • 7.5.3.1. China: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.3.2. China: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.4. Anticoagulant Reversal Drugs Market - India
      • 7.5.4.1. India: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.4.2. India: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.5. Anticoagulant Reversal Drugs Market - Malaysia
      • 7.5.5.1. Malaysia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.6. Anticoagulant Reversal Drugs Market - Japan
      • 7.5.6.1. Japan: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.7. Anticoagulant Reversal Drugs Market - Indonesia
      • 7.5.7.1. Indonesia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.8. Anticoagulant Reversal Drugs Market - South Korea
      • 7.5.8.1. South Korea: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.9. Anticoagulant Reversal Drugs Market - Australia
      • 7.5.9.1. Australia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.10. Anticoagulant Reversal Drugs Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.6. Anticoagulant Reversal Drugs Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.3. Anticoagulant Reversal Drugs Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.4. Anticoagulant Reversal Drugs Market - UAE
      • 7.6.4.1. UAE: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.5. Anticoagulant Reversal Drugs Market - Israel
      • 7.6.5.1. Israel: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.6. Anticoagulant Reversal Drugs Market - South Africa
      • 7.6.6.1. South Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.7. Anticoagulant Reversal Drugs Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.7. Anticoagulant Reversal Drugs Market - Latin America
    • 7.7.1. Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.3. Anticoagulant Reversal Drugs Market - Mexico
      • 7.7.3.1. Mexico: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.4. Anticoagulant Reversal Drugs Market - Brazil
      • 7.7.4.1. Brazil: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.5. Anticoagulant Reversal Drugs Market - Argentina
      • 7.7.5.1. Argentina: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.6. Anticoagulant Reversal Drugs Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Alps Pharmaceutical Ind. Co., Ltd.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. AMAG Pharmaceuticals, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Bausch Health Companies Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boehringer Ingelheim
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. CSL Behring
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Dr. Reddy's Laboratories
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Fresenius Kabi AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Octapharma AG
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Pfizer, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Portola Pharmaceuticals
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Covis Pharma
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Hisamitsu Pharmaceutical Co., Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development

List of Tables:

  • Table 1 Global Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 2 Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 3 North America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 4 North America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 5 U.S.: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 6 U.S.: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 Canada: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 8 Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 9 Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 10 Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 11 UK: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 12 UK: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 France: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 14 France: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 15 Germany: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 16 Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 17 Italy: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 18 Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 19 Spain: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 20 Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 21 Netherlands: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 22 Netherlands: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 23 Russia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 24 Russia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 29 China: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 30 China: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 31 India: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 32 India: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 33 Malaysia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 34 Malaysia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 35 Japan: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 36 Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 37 Indonesia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 38 Indonesia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 39 South Korea: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 40 South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 41 Australia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 42 Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 49 UAE: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 50 UAE: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 51 Israel: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 52 Israel: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 53 South Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 54 South Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 57 Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 58 Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 59 Mexico: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 60 Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 61 Brazil: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 62 Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 63 Argentina: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 64 Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Anticoagulant Reversal Drugs Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Anticoagulant Reversal Drugs Market, by Product, 2024 & 2034 (USD Million)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2024 & 2034 (USD Million)